Showing results (231-240 of 369) with videos related to
Sort By:
Pageof 37
Frontiers in Psychiatry|July 7, 2020
Safety and Tolerability of Both Arm Ischemic Conditioning in Patients With Major Depression: A Proof of Concept StudyZuowei Wang, Xujuan Li, Ningning Li, et al.Journal of Molecular Neuroscience : MN|January 15, 2013
Neurotrophic tyrosine kinase receptor type 2 (NTRK2) gene associated with treatment response to mood stabilizers in patients with bipolar I disorderZuowei Wang, Jinbo Fan, Keming Gao, et al.General Psychiatry|March 13, 2024
Brain-wide activation involved in 15 mA transcranial alternating current stimulation in patients with first-episode major depressive disorderJie Wang, Wenfeng Zhao, Huang Wang, et al.Psychiatry Research|May 19, 2015
Posttraumatic stress disorder's dysphoria dimension and relations with generalized anxiety disorder symptomsTory A Durham, Jon D Elhai, Thomas H Fine, et al.Psychiatric Services (Washington, D.C.)|September 3, 2009
A comparison of the life goals program and treatment as usual for individuals with bipolar disorderMartha Sajatovic, Marilyn A Davies, Stephen J Ganocy, et al.Journal of Affective Disorders|February 11, 2015
Structural relations between DSM-5 PTSD and major depression symptoms in military soldiersJon D Elhai, Ateka A Contractor, Marijo Tamburrino, et al.The American Journal of Psychiatry|July 5, 2005
A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depressionJoseph R Calabrese, Paul E Keck, Wayne Macfadden, et al.The British Journal of Psychiatry : the Journal of Mental Science|December 2, 2004
Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric maniaRobert W Baker, Eileen Brown, Hagop S Akiskal, et al.Psychopharmacology|August 29, 2012
Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophreniaJian-Jun Ou, Yi Xu, Hong-Hui Chen, et al.The Journal of Clinical Psychiatry|October 27, 2007
Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placeboPaul E Keck, Joseph R Calabrese, Roger S McIntyre, et al.Pageof 37